Brief: Xspray Pharma Appoints Blake Leitch As CEO
26/02/2026 06:46
Feb 26 (Reuters) - XSpray Pharma AB (publ) XSPRAY.ST: XSPRAY PHARMA APPOINTS BLAKE LEITCH AS CEO – PER ANDERSSON CONTINUES AS CHIEF SCIENTIFIC OFFICER (CSO) APPOINTMENT EFFECTIVE NO LATER THAN JUNE 1, 2026 Source text: ID:nMFN4yR11Y Further company coverage: XSPRAY.ST (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Xspray Pharma publ AB
See all newsBrief: Xspray Pharma Gets CRL From FDA
Sweden's Xspray Q1 loss narrows, upbeat on Dasynoc prospects
Brief: Xspray Pharma Q1 Pretax Loss SEK 35.4 Mln
Brief: Xspray Pharma To Receive About SEK 113 Million From Rights, Over-Allotment Issues
Brief: FDA Accepts Trade Name Nilopki For Xspray's Drug Candidate XS003